Description: Clinical trials for adults with mild Alzheimer’s disease.
dementia (883) memory (831) alzheimer (558) alzheimer's disease (134) mci (73) alzheimer’s (69) mild cognitive impairment (14) cognitive impairment (9) apoe4 (2) dementia alzheimer's type (1)
The ASCENT clinical trials are evaluating an investigational drug called PRX012.
You may be eligible to participate if you are 55 to 85 years old with mild Alzheimer’s disease (AD) or mild cognitive impairment due to AD.
The ASCENT clinical trials will take place at several locations. Click here to view our map and find a participating site location near you.